Semnur Pharmaceuticals SMNR Income Statement (2022-2026)

OTC SMNR
$0.37 -0.01 (-2.63%)
At close: Oct 23, 2026 · 4:00 PM EDT
Reported Financials

Semnur Pharmaceuticals Quarterly Income Statement

Periods 18 quarters
Latest Jun 2026

Semnur Pharmaceuticals reported net income of -$4.35M for the quarter ended Jun 2026. This income statement covers 18 quarters of results from Mar 2022 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Income StatementIncome Statement Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating items
Research & DevelopmentR&D 0.23M0.24M0.19M0.50M1.14M0.71M1.27M1.25M
Selling, General & AdministrativeSG&A 1.07M0.54M0.48M0.50M151.45M5.44M3.31M2.98M
Other Operating ExpensesOther Opex 0.01M0.15M0.07M1.41M1.92M0.56M0.51M0.18M0.15M0.11M0.13M0.06M
Operating ExpensesOpex 0.01M0.15M0.07M1.41M1.92M0.56M0.51M0.18M0.37M0.17M1.30M0.78M0.67M1.00M152.59M6.16M4.58M4.22M
Operating IncomeOp. Inc -0.56M-0.51M-0.18M-0.37M-0.17M-1.30M-0.78M-0.67M-1.00M-152.59M-6.12M-4.60M-4.22M
EBIT -0.56M-0.51M-0.18M-0.37M-0.17M-1.30M-0.78M-0.67M-1.00M-152.59M-6.12M-4.60M-4.22M
Non-operating items
Non Operating Interest Expenses 0.01M0.02M0.02M0.02M0.03M0.03M0.03M0.12M
Interest & Investment IncomeInt & Inv Inc 0.11M0.38M0.73M0.91M1.03M1.15M0.75M0.65M0.64M0.20M0.09M0.08M0.02M
Non Operating IncomeNon Op. Inc. -0.12M
Net income details
EBT 0.46M0.63M0.55M0.26M0.45M-1.13M-0.72M-0.61M-0.98M-152.59M-6.12M-4.60M-4.35M
Profit After TaxPAT 0.46M0.63M0.55M0.26M0.45M-1.13M-0.72M-0.61M-0.98M-152.59M-6.12M-4.60M-4.35M
Income from Continuing OperationsIncome (Continuing) 0.46M0.63M0.55M0.26M0.45M-1.13M-0.72M-0.61M-0.98M-152.59M-6.12M-4.60M-4.35M
Consolidated Net IncomeConsol Net Inc. 0.46M0.63M0.55M0.26M0.45M-1.13M-0.72M-0.61M-0.98M-152.59M-6.12M-4.60M-4.35M
Income towards Parent CompanyParent Net Inc -0.01M-0.03M0.31M-0.68M-1.01M0.46M0.63M0.55M-1.51M-1.11M-1.30M-0.17M-0.67M-1.00M-152.59M-6.16M-4.58M-4.35M
Net Income towards Common StockholdersNet Income -0.01M-0.03M0.31M-0.68M-1.01M0.46M0.63M0.63M0.26M0.45M-0.04M-0.17M-0.19M-0.39M-152.59M-6.16M-4.58M-4.35M
Additional items
EPS (Basic) 0.000.000.01-0.04-0.050.020.030.060.020.030.000.000.000.00-0.76-0.03-0.02-0.02
EPS (Diluted) 0.000.000.01-0.04-0.050.010.010.030.040.060.000.000.000.00-0.76-0.03-0.02-0.02
Shares Outstanding 2.49M19.68M21.65M16.58M21.65M21.65M21.65M9.99M14.22M14.22M200.00M200.00M200.00M200.00M201.69M204.78M230.21M230.21M
Shares Outstanding (Diluted)Shares Outstanding (Dil.) 2.49M19.68M43.29M16.58M21.65M43.29M43.29M19.98M7.11M7.11M200.00M200.00M200.00M200.00M201.69M204.78M230.21M230.21M
Shares Outstanding (Entity)Shares Outstanding (Entity.) 24.32M17.52M17.52M16.58M17.52M17.52M21.65M9.99M14.22M14.22M200.00M200.00M200.00M200.00M229.74M230.21M230.21M230.21M
Interest ExpensesInt Expense 0.01M0.02M0.02M0.02M0.03M0.03M0.03M0.12M

Semnur Pharmaceuticals Income Statement API

Pull Semnur Pharmaceuticals's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=SMNR&statement=IS&frequency=Quarter&period=all&api_key=YOUR_API_KEY